E. Sampol et al., EVIDENCE FOR A TISSUE-SPECIFIC INDUCTION OF CUTANEOUS CYP2E1 BY DEXAMETHASONE, Biochemical and biophysical research communications, 235(3), 1997, pp. 557-561
We studied in mouse the effect of topical application of dexamethasone
or salicylic acid, on CYP2E1 and CYP3A expression (proteins and/or mR
NA) in liver and skin. Dexamethasone was also administered by intraper
itoneal injection. Topical application or intraperitoneal injection of
dexamethasone increased cutaneous CYP2E1 (8 and 4-fold respectively)
whereas the hepatic level of this isoform showed a slight decrease and
hepatic CYP3A expression was increased (3-fold). Cutaneous CYP2E1 was
increased (3-fold) after topical treatment by salicylic acid, This co
mpound had no effect on hepatic CYP3A and CYP2E1 expression. Cutaneous
CYP3A (protein and mRNA) was not detectable in all groups (control or
treated animals). Dexamethasone and salicylic acid increased cutaneou
s CYP2E1 mRNA level (2.5 and 1.4-fold respectively). In conclusion, de
xamethasone and salicylic acid induced cutaneous CYP2E1 protein and mR
NA level. Cutaneous CYP2E1 induction by dexamethasone is a tissue-spec
ific process. (C) 1997 Academic Press.